Yuva Biosciences, Inc.
BIRMINGHAM, AL · Founded 2019 · CIK 0001998258 · Biotech · Private
AI platform for discovering compounds that improve mitochondrial health and aging-related diseases; commercialized therapeutic products including Y100 for hair loss
yuvabio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $1.1M
- 2 Form D · Mar 2026
- 7 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 0 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,500,000 | |
| Private capital raised | Form D · SEC | $1,118,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1606 | Reglagene, LLC | — | $1.9M |
| 1607 | XenoTherapeutics Corp | — | $1.3M |
| 1608 | RIBO-THERAPEUTICS LLC | — | — |
| 1609 | Yuva Biosciences, Inc. | — | $1.1M |
| 1610 | CEL-SCI CORPORATION | — | $1.1M |
| 1611 | CELL ORIGINS, LLC | — | — |
| 1612 | GATC HEALTH CORP | — | $981K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Daniel BrowneDirector
- Fred EhrsamDirector
- Greg SchmergelDirector · Executive Officer
Patents
- Compositions And Methods For Treating Ovarian Aging, Ovarian Diseases And Conditions, And Symptoms Thereofapplication
- Compositions And Methods For Improving Mitochondrial Functionapplication
- Compositions And Methods For Treating COVID-19 And Symptoms Thereofapplication
- Conjugate Compounds For Enhancement Of Mitochondrial Healthapplication
- Delivery System For Mitochondrial Health Enhancersapplication
- Conjugate Compounds For Enhancement Of Mitochondrial Healthapplication
- Compositions And Methods For Treating Ovarian Aging, Ovarian Diseases And Conditions, And Symptoms Thereofapplication
- Compositions And Methods For Improving Mitochondrial Functionapplication
- Compositions And Methods For Treating Ovarian Diseases And Conditions And Symptoms Thereofapplication
- Compositions And Methods For Treating COVID-19 And Symptoms Thereofapplication
- Compositions And Methods For Improving Mitochondrial Functionapplication
- Compositions And Methods For Wound And Scar Healingapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.